ClinicalTrials.Veeva

Menu

Outcome, Recuperation and Hemodynamics in Aortic Stenosis (PROCARE-AS)

J

Jessa Hospital

Status

Unknown

Conditions

Aortic Valve Stenosis

Treatments

Diagnostic Test: CPET, 6MWT, QOL assessment

Study type

Interventional

Funder types

Other

Identifiers

NCT05272020
f/2020/173

Details and patient eligibility

About

Indication for aortic valve replacement (AVR) in aortic stenosis (AS) is currently based on the classical triad of clinical AS symptoms, estimation of AS severity, and cardiac repercussion at rest. However, presence of symptoms in elderly is often subjective and underreported, and cardiac function analysis at rest underestimates the true impact of the chronic afterload increase. This complicates the diagnosis and hampers timely aortic valve replacement therapy with an impact on prognosis and cardiac function recovery. Exercise imaging in AS may reveal underlying cardiac repercussion and symptoms at an earlier stage and therefore impact prognosis and cardiac function recovery after AVR. Therefore the principal objective of this study is to reveal the factors that determine clinical outcome and hemodynamic function recovery after AVR in AS.

Enrollment

150 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Every patient above 18 years of age with an echocardiographic established moderate to severe AS
  • A guideline indication for aortic valve replacement therapy

Exclusion criteria

  • Unable to perform exercise testing
  • Previous aortic valve intervention
  • More than moderate other valvular disease
  • Patients refusing participation or unwilling to sign the informed consent

Trial design

Primary purpose

Diagnostic

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

150 participants in 2 patient groups

TAVI
Other group
Description:
Cardiopulmonary exercise testing, 6 minute walking test, QOL assessment
Treatment:
Diagnostic Test: CPET, 6MWT, QOL assessment
AVR
Other group
Description:
Cardiopulmonary exercise testing, 6 minute walking test, QOL assessment, Myocardial + aortic valve biopsy
Treatment:
Diagnostic Test: CPET, 6MWT, QOL assessment

Trial contacts and locations

1

Loading...

Central trial contact

Sarah Hoedemakers, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems